---
title: "Adial Pharmaceuticals Changes Name to Azora Therapeutics"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303445643.md"
description: "Adial Pharmaceuticals has officially changed its name to Azora Therapeutics, shifting focus to inflammatory disease treatments. Common stock will trade on Nasdaq under ticker AZR starting October 29, 2026. Matt Davidson was appointed president and CEO. The company's lead candidate, AT177 for ulcerative colitis, is expected to enter Phase 1 trials in the first half of 2027. Current cash reserves are projected to fund operations through 2028."
datetime: "2026-10-28T20:03:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303445643.md)
  - [en](https://longbridge.com/en/news/303445643.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303445643.md)
generator: "portal-rs"
---

# Adial Pharmaceuticals Changes Name to Azora Therapeutics

-   Adial Pharmaceuticals changed its name to Azora Therapeutics, focusing on treatments for inflammatory diseases. \* Common stock is expected to begin trading on Nasdaq under ticker AZR on October 29, 2026. \* Matt Davidson was appointed president and chief executive officer to lead the new executive team. \* Lead candidate AT177, an oral, colon-targeted AhR agonist for ulcerative colitis, is expected to enter Phase 1 trials in first-half 2027. \* Current cash and cash equivalents are expected to fund operational plans into 2028. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610281602PRIMZONEFULLFEED9855512) on October 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [AZR.US](https://longbridge.com/en/quote/AZR.US.md)

## Related News & Research

- [Adial Pharmaceuticals Completes Azora Merger, Shifts Strategic Focus](https://longbridge.com/en/news/289496601.md)
- [Major Investor Quietly Boosts Stake in Adial Pharmaceuticals](https://longbridge.com/en/news/291495678.md)
- [Lumentum President and CEO Michael E. Hurlston Reports Disposal of $4.48 Million in Common Shares](https://longbridge.com/en/news/305879399.md)
- [Eli Lilly (LLY) Enters Cancer Licensing Deal Worth $5.9 Billion](https://longbridge.com/en/news/305855448.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**